AVITHRAPID - Standard Operating Procedure - Cytotoxicity Cell Viability assay
Key Points
The aim is to outline a procedure to evaluate the cytotoxic effects of various test compounds.
Describes a luminescence-based assay for measuring cell viability.
Applicable within the AVITHRAPID project for screening test compounds.
Demonstrates the effectiveness of the luminescence assay for detecting cytotoxicity of test compounds.
Abstract
This Standard Operating Procedure (SOP) defines the method for evaluating the cytotoxicity of test compounds within the AVITHRAPID project using a luminescence-based cell viability assay.